-

GE Healthcare Unveils Voluson SWIFT, AI-Enhanced Women’s Health Ultrasound with Industry-First Auto Recognition Tools to Help Improve Efficiency

  • Voluson SWIFT redefines the ultrasound experience for women’s health practitioners by integrating intelligent features that can reduce patient scanning time by as much as 45 percent and automate exam measurements resulting in significant time savings for users.
  • World’s first ultrasound system with fully integrated AI that recognizes the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynecology mid-trimester practice guidelines for fetal imaging, optimizing the scan workflow by 73 percent when compared to manual 2D workflow.1

CHICAGO--(BUSINESS WIRE)--GE Healthcare today unveiled Voluson SWIFT*, a new ultrasound system designed to help women’s health clinicians expand diagnostic capabilities and improve patient outcomes. The system features industry-first AI algorithms to support auto recognition in addition to an ergonomic design, impeccable image quality, and tools to improve efficiency.

A recent study found that obstetrics (OB) and gynecology (GYN) clinicians in the United States have some of the highest burnout rates among physicians, with the leading factor being bureaucratic tasks like paperwork, charting, and patient data capture.2 In today’s COVID-19 pandemic environment, these clinicians are now facing additional pressures to see more patients and perform exams quickly to limit possible patient exposure to the coronavirus.

To help combat these constraints and improve clinical outcomes, GE Healthcare gathered input from 200 women’s health practitioners worldwide to develop the all-new Voluson SWIFT that is designed to help make clinician’s daily work more manageable. New features allow users to customize the system to their personal preferences and the system comes with guided workflows to help new users learn the technology faster and use it more effectively.

“The Voluson SWIFT is intuitive to use and comes with many options to personalize your preferences on the system and auto-measurement tools that allow you to focus on the examination rather than time-consuming adjustments,” said Dr. Ralf Menkhaus, Gynecologist at Kinderwunschzentrum in Minden, Germany. “It’s like the machine is helping do some of the thinking for you which has allowed me to seamlessly integrate it for any obstetric and gynecological exams I need to do.”

The Voluson SWIFT ultrasound system features an embedded artificial intelligence platform, including the new SonoLyst** application, the industry’s first fully integrated AI tool that recognizes the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynecology mid-trimester practice guidelines for fetal imaging, optimizing the scan workflow by 73 percent when compared to manual 2D workflow. Additional benefits include:

  • Scan Assistant tool that guides clinicians through protocols and reduces the patient scanning time by up to 45 percent, with simplified workflow and freedom to customize and create your own user protocols.3,4
  • SonoBiometry measurements are now 38 percent faster than previous platforms and three additional measurements to SonoBiometry make Voluson SWIFT 60 percent more automated than previous systems.5
  • Utilizing SonoCNS, developed on GE Healthcare’s Edison intelligence platform, on the Voluson SWIFT can help reduce keystrokes by 78 percent when obtaining desired planes and measurements of the fetal central nervous system (CNS).6

Voluson SWIFT has redefined one of the most essential tools obstetrics and gynecology clinicians rely on, delivering a contemporary design, intuitive user interface, and intelligent workflow supported by AI,” said Roland Rott, General Manager of Women’s Health Ultrasound at GE Healthcare. “In today’s environment where cleanliness and time savings opportunities are critical for clinicians, we’re proud to offer a solution that makes our customers’ work easier and gives them time back with their patients.”

To learn more about GE Healthcare’s Voluson SWIFT technology, click here.

*510(k) pending at FDA. Not available for sale in the United States.

**SonoLyst incorporates the AI technology of Intelligent Ultrasound

About GE Healthcare

GE Healthcare is the $16.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

1 Comparison performed using GE Healthcare’s Voluson SWIFT/ SWIFT+ compared to Voluson P8.

2 Accessed on 9/22/2020: https://www.medscape.com/slideshow/2020-lifestyle-obgyn-6012501

3 Comparison performed using GE’s Voluson SWIFT/ SWIFT+ vs. Voluson P8.

4 Comparison performed using GE’s Voluson SWIFT/ SWIFT+ vs. Voluson P8 BT18 & Voluson S6 BT16.

5 Comparison performed using GE’s Voluson SWIFT/SWIFT+ and GE’s Voluson P8 BT18.

6 Sonographic examination of the fetal central nervous system: guidelines for performing the „basic examination“ and the „fetal neurosonogram“ [Ultrasound Obstet. Gynecol. 2007; 29: 109–116]

Contacts

Kate Rodgers
GE Healthcare
+1 815 388 5697
Katlynn.Rodgers@ge.com

GE Healthcare

NYSE:GE

Release Summary
Voluson SWIFT redefines the ultrasound experience for women’s health practitioners by integrating intelligent features and contemporary design.
Release Versions

Contacts

Kate Rodgers
GE Healthcare
+1 815 388 5697
Katlynn.Rodgers@ge.com

More News From GE Healthcare

GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that View, the powerful viewer within the Genesis™ Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Designed as a fast, diagnostic, zero‑footprint viewer, View serves as the core anchor of the Genesis Radiology Workspace.2 This next‑generation solution aims to transform radiology workflows, unify the user experience, and empower radiologists with greater efficiency and precision. Studies...

GE HealthCare to showcase AI and digital leadership at HIMSS 2026

LAS VEGAS--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will showcase innovations moving healthcare forward at the Health Information and Management Systems Society (HIMSS) Global Health Conference & Exhibition 2026 in Las Vegas from March 9-12, 2026. This year, GE HealthCare will spotlight meaningful technology transforming the way healthcare professionals approach patient care, from imaging operations and fleet management to enterprise solutions, ultrasound, and patient care technologies...

GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food and Drug Administration (FDA): SIGNA™ Sprint with Freelium™1, a 1.5T sealed magnet MRI system; SIGNA™ Bolt2, an advanced 3T MRI scanner; and SIGNA™ One3, an AI-driven ecosystem of workflow solutions designed to help reduce inefficiencies and support MRI exams from plan to scan and beyond. The new MRI systems and technology combat some of the...
Back to Newsroom